Document Type : Original Article(s)
Authors
- Sabah Mohamed Hanafy 1, 2
- Abdelmonem Awad Hegazy 3, 4
- Fayig Elmigdadi 3
- Ibrahim Mahmoud Eladl 5
- Ahmed Embaby 6
- Mohamed Abdallah Zaitoun 7
- Basma A. Ibrahim 8
- Mona Ahmed Abdelmaksoud 9
- Heba Mahmoud Abdelgeleel 1
- Mona Mahmoud Eladl 5
- Abeer H Abdelkader 9
- Mai Ahmed Gobran 1
1 Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2 Laboratory Medicine Department, Applied Medical Science, Al-Baha University, Al-Baha, Saudi Arabia
3 Basic Medical Science Department, Faculty of Dentistry, Zarqa University, Zarqa, Jordan
4 Human Anatomy and Embryology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
5 Diagnostic Radiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
6 Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
7 General Surgery Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
8 Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
9 Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Abstract
Background: Colorectal cancer (CRC) is one of the most malignancies worldwide. This study aimed to determine the role of leptin and cyclin D1 in CRC and their association with clinicopathological parameters and clinical outcomes of patients, and to compare them with normal tissues.
Method: A retrospective study was carried out on 60 specimens classified as 8 normal colonic mucosae, 40 patients suspected to have CRC, and 12 colonic dysplasia (CD) and were evaluated in terms of tumor node metastases staging using multislice computerized tomography scan, quantitative real-time polymerase chain reaction to calculate relative leptin mRNA expression level; and immunohistochemical staining was performed to study leptin and cyclin D1 expressions in CRC and CD versus the normal colonic mucosa. Normal mucosa was obtained by colonoscopy from patients for causes other than neoplasia or dysplasia. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS 24 Inc. Chicago, IL, USA) with a significance value of P ≤ 0.05.
Results: There was a significant association between leptin and cyclin D1 positive expressions and both CRC and CD. However, poor clinical outcome was significantly correlated with high positive leptin and cyclin D1 expressions detected in CRC patients. Cyclin D1 and leptin showed a strong association with greater histological grade, stage, positive LN, and distant metastases of CRC.
Conclusion: Expressions of leptin and cyclin D1 are associated with colon disorders with unfavorable outcomes in colon cancer. New opportunities may emerge from the discovery of cross-talk between leptin and other oncogenic pathways in obesity-related cancers, with a particular focus on colon cancer.
Highlights
Sabah Mohamed Hanafy (PubMed)
Abdelmonem Awad Hegazy (Google Scholar)
Keywords
Main Subjects
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination, and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.30476/mejc.2024.103151.2126
- Al-Shamsi HO, Jones J, Fahmawi Y, Dahbour I, Tabash A, Abdel-Wahab R, et al. Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern. J Gastrointest Oncol. 2016;7(6):882-902. doi: 10.21037/jgo.2016.11.02. PMID: 28078112; PMCID: PMC5177568.
- Rodriguez R, Perkins BD, Park PY, Koo P, Kundranda MN, Chang J. Early colorectal cancer detection on routine CT to improve patient's 5-year survival. J Clin Oncol. 2018;36(4_suppl):593. doi:10.1200/jco.2018.36.4_suppl.593.
- Elibol FD, Obuz F, Sökmen S, Terzi C, Canda AE, Sağol Ö, et al. The role of multidetector CT in local staging and evaluation of retroperitoneal surgical margin involvement in colon cancer. Diagn Interv Radiol. 2016;22(1):5-12. doi: 10.5152/dir.2015.15089. PMID: 26611110; PMCID: PMC4712898.
- Harb OA, Hegazy AA, Gertallah L, Haggag RM, Mostafa SH. Prognostic value of immunohistochemical expressions of the stem cell biomarker "LGR5" and the proliferation biomarker "TPX2" in colorectal carcinoma. J Tum. 2016;4(3):426-34. doi:10.17554/j.issn.1819-6187.2016.04.93.
- Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: Epidemiology, risk factors, and prevention. Cancers (Basel). 2024;16(8):1530. doi: 10.3390/cancers16081530. PMID: 38672612; PMCID: PMC11049480.
- Socol CT, Chira A, Martinez-Sanchez MA, Nuñez-Sanchez MA, Maerescu CM, Mierlita D, et al. Leptin signaling in obesity and colorectal cancer. Int J Mol Sci. 2022;23(9):4713. doi: 10.3390/ijms23094713. PMID: 35563103; PMCID: PMC9102849.
- Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64(1):24-34. doi: 10.1016/j.metabol.2014.08.004. PMID: 25199978; PMCID: PMC4267898.
- Kamel HFM, Nassir AM, Al Refai AA. Assessment of expression levels of leptin and leptin receptor as potential biomarkers for risk of prostate cancer development and aggressiveness. Cancer Med. 2020;9(15):5687-96. doi: 10.1002/cam4.3082. PMID: 32573960; PMCID: PMC7402836.
- Kim HR. Obesity-related colorectal cancer: The role of leptin. Ann Coloproctol. 2015;31(6):209-10. doi: 10.3393/ac.2015.31.6.209. PMID: 26812923; PMCID: PMC4724700.
- Caruso A, Gelsomino L, Panza S, Accattatis FM, Naimo GD, Barone I, et al. Leptin: A heavyweight player in obesity-related cancers. Biomolecules. 2023;13(7):1084. doi: 10.3390/biom13071084. PMID: 37509120; PMCID: PMC10377641.
- Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl). 2016;94(12):1313-1326. doi: 10.1007/s00109-016-1475-3. PMID: 27695879; PMCID: PMC5145738.
- Li Y, Wei J, Xu C, Zhao Z, You T. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies. PLoS One. 2014;9(4):e94508. doi: 10.1371/journal.pone.0094508. PMID: 24728073; PMCID: PMC3984178.
- Ahlin C, Lundgren C, Embretsén-Varro E, Jirström K, Blomqvist C, Fjällskog ML. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers. Breast Cancer Res Treat. 2017;164(3):667-78. doi: 10.1007/s10549-017-4294-5. PMID: 28528450; PMCID: PMC5495873.
- Li J, Guo BC, Sun LR, Wang JW, Fu XH, Zhang SZ, et al. TNM staging of colorectal cancer should be reconsidered by T stage weighting. World J Gastroenterol. 2014;20(17):5104-12. doi: 10.3748/wjg.v20.i17.5104. PMID: 24803826; PMCID: PMC4009548.
- Hegazy R, Hegazy A. Hegazy’ simplified method of tissue processing (consuming less time and chemicals). Ann Int Med Dent Res. 2015;1(2):57-61.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402-8. doi: 10.1006/meth.2001.1262. PMID: 11846609.
- Handa K, Yamakawa M, Takeda H, Kimura S, Takahashi T. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer. 1999;84(3):225-33. doi: 10.1002/(sici)1097-0215(19990621)84:3<225::aid-ijc5>3.0.co;2-a. PMID: 10371338.
- Al-Maghrabi J, Mufti S, Gomaa W, Buhmeida A, Al-Qahtani M, Al-Ahwal M. Immunoexpression of cyclin D1 in colorectal carcinomas is not correlated with survival outcome. J Microsc Ultrastruct. 2015;3(2):62-7. doi: 10.1016/j.jmau.2015.01.001. PMID: 30023183; PMCID: PMC6014192.
- Albasri AM, Elkablawy MA, Ansari IA, Alhujaily AS. Prognostic Significance of Cyclin D1 Over-expression in Colorectal Cancer: An Experience from Madinah, Saudi Arabia. Asian Pac J Cancer Prev. 2019;20(8):2471-6. doi: 10.31557/APJCP.2019.20.8.2471. PMID: 31450922; PMCID: PMC6852817.
- Abd-El Raouf SM, Ibrahim TR, Hegazy AA. Expression and significance of ezrin and E-cadherin in colorectal carcinoma. Int J Adv Res. 2014;2:936-44.
- Bardou M, Rouland A, Martel M, Loffroy R, Barkun AN, Chapelle N. Review article: obesity and colorectal cancer. Aliment Pharmacol Ther. 2022;56(3):407-18. doi: 10.1111/apt.17045. PMID: 35707910.
- Caruso A, Gelsomino L, Panza S, Accattatis FM, Naimo GD, Barone I, et al. Obesity-related cancers. Biomolecules. 2023;13(7):1084. doi: 10.3390/biom13071084. PMID: 37509120; PMCID: PMC10377641.
- Li C, Quan J, Wei R, Zhao Z, Guan X, Liu Z, et al. Leptin overexpression as a poor prognostic factor for colorectal cancer. Biomed Res Int. 2020;2020:7532514. doi: 10.1155/2020/7532514. PMID: 32596369; PMCID: PMC7292990.
- Wangefjord S, Manjer J, Gaber A, Nodin B, Eberhard J, Jirström K. Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study. Biol Sex Differ. 2011;2:10. doi: 10.1186/2042-6410-2-10. PMID: 21888663; PMCID: PMC3179695.
- Jun SY, Kim J, Yoon N, Maeng LS, Byun JH. Prognostic potential of Cyclin D1 expression in colorectal cancer. J Clin Med. 2023;12(2):572. doi: 10.3390/jcm12020572. PMID: 36675501; PMCID: PMC9867305.
- Erkasap N, Ozyurt R, Ozkurt M, Erkasap S, Yasar F, Ihtiyar E, et al. Role of Notch, IL-1 and leptin expression in colorectal cancer. Exp Ther Med. 2021;21(6):600. doi: 10.3892/etm.2021.10032. PMID: 33884038; PMCID: PMC8056113.
- Al-Maghrabi JA, Qureshi IA, Khabaz MN. Expression of leptin in colorectal adenocarcinoma showed significant different survival patterns associated with tumor size, lymphovascular invasion, distant metastasis, local recurrence, and relapse of disease in the western province of Saudi Arabia. Medicine (Baltimore). 2018;97(34):e12052. doi: 10.1097/MD.0000000000012052. PMID: 30142858; PMCID: PMC6113030.
- Perumal K, Mun KS, Yap NY, Razack AHA, Gobe GC, Ong TA, Kuppusamy S, Rajandram R. A Study on the immunohistochemical expressions of leptin and leptin receptor in clear cell renal cell carcinoma. Biomed Res Int. 2020;2020:3682086. doi: 10.1155/2020/3682086. PMID: 32802842; PMCID: PMC7424391.
- de Candia P, Prattichizzo F, Garavelli S, Alviggi C, La Cava A, Matarese G. The pleiotropic roles of leptin in metabolism, immunity, and cancer. J Exp Med. 2021;218(5):e20191593. doi: 10.1084/jem.20191593. PMID: 33857282; PMCID: PMC8056770.
- Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Endocr Relat Cancer. 2007;14(2):513-29. doi: 10.1677/ERC-06-0027. PMID: 17639064.
- Lin TC, Hsiao M. Leptin and cancer: Updated functional roles in carcinogenesis, therapeutic niches, and developments. Int J Mol Sci. 2021;22(6):2870. doi: 10.3390/ijms22062870. PMID: 33799880; PMCID: PMC8002181.
- Palaiologos P, Chrysikos D, Theocharis S, Kouraklis G. The Prognostic value of G1 cyclins, p21 and Rb protein in patients with colon cancer. Anticancer Res. 2019;39(11):6291-6297. doi: 10.21873/anticanres.13839. PMID: 31704859.
- Jeong WK, Baek SK, Kim MK, Kwon SY, Kim HS. Prognostic significance of tissue leptin expression in colorectal cancer patients. Ann Coloproctol. 2015;31(6):222-7. doi: 10.3393/ac.2015.31.6.222. PMID: 26817017; PMCID: PMC4724703.
- Rivadeneira DB, DePeaux K, Wang Y, Kulkarni A, Tabib T, Menk AV, et al. Oncolytic viruses engineered to enforce leptin expression reprogram tumor-infiltrating T cell metabolism and promote tumor clearance. Immunity. 2019;51(3):548-560.e4. doi: 10.1016/j.immuni.2019.07.003. PMID: 31471106; PMCID: PMC6903394.
- Jiménez-Cortegana C, López-Saavedra A, Sánchez-Jiménez F, Pérez-Pérez A, Castiñeiras J, Virizuela-Echaburu JA, et al. Leptin, Both Bad and Good Actor in Cancer. Biomolecules. 2021;11(6):913. doi: 10.3390/biom11060913. PMID: 34202969; PMCID: PMC8235379.
- Cohen-Mekelburg S, Schneider Y, Gold S, Scherl E, Steinlauf A. Advances in the diagnosis and management of colonic dysplasia in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2017;13(6):357-62. PMID: 28690452; PMCID: PMC5495039.
- Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004;287(1):G7-17. doi: 10.1152/ajpgi.00079.2004. PMID: 15194558.